{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T15:54:42Z","timestamp":1777046082491,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82070817"],"award-info":[{"award-number":["No. 82070817"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-023-02100-9","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T15:02:33Z","timestamp":1685718153000},"page":"2471-2479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["PTH level might be associated with impaired quality of life in patients with nonsurgical hypoparathyroidism"],"prefix":"10.1007","volume":"46","author":[{"given":"A.","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0395-8789","authenticated-orcid":false,"given":"O.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2759-5177","authenticated-orcid":false,"given":"X.","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"2100_CR1","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1002\/jbmr.2501","volume":"30","author":"L Underbjerg","year":"2015","unstructured":"Underbjerg L, Sikjaer T, Mosekilde L et al (2015) The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study. J Bone Miner Res 30:1738\u20131744","journal-title":"J Bone Miner Res"},{"key":"2100_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2188\/jea.10.29","volume":"10","author":"Y Nakamura","year":"2000","unstructured":"Nakamura Y, Matsumoto T, Tamakoshi A et al (2000) Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan. J Epidemiol 10:29\u201333","journal-title":"J Epidemiol"},{"key":"2100_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2265.1994.tb03923.x","volume":"40","author":"A Halabe","year":"1994","unstructured":"Halabe A, Arie R, Mimran D et al (1994) Hypoparathyroidism\u2013a long-term follow-up experience with 1 alpha-vitamin D3 therapy. Clin Endocrinol (Oxf) 40:303\u2013307","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2100_CR4","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1136\/bmj.39582.589433.BE","volume":"336","author":"MS Cooper","year":"2008","unstructured":"Cooper MS, Gittoes NJ (2008) Diagnosis and management of hypocalcaemia. BMJ 336:1298\u20131302","journal-title":"BMJ"},{"key":"2100_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-0447.1962.tb01780.x","volume":"38","author":"JD Denko","year":"1962","unstructured":"Denko JD, Kaelbling R (1962) The psychiatric aspects of hypoparathyroidism. Acta Psychiatr Scand Suppl 38:1\u201370","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"2100_CR6","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1530\/eje.0.1460215","volume":"146","author":"W Arlt","year":"2002","unstructured":"Arlt W, Fremerey C, Callies F et al (2002) Well-being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol 146:215\u2013222","journal-title":"Eur J Endocrinol"},{"key":"2100_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s12020-017-1377-3","volume":"58","author":"M Buttner","year":"2017","unstructured":"Buttner M, Musholt TJ, Singer S (2017) Quality of life in patients with hypoparathyroidism receiving standard treatment: a systematic review. Endocrine 58:14\u201320","journal-title":"Endocrine"},{"key":"2100_CR8","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1210\/jc.2017-01555","volume":"103","author":"A Palermo","year":"2018","unstructured":"Palermo A, Santonati A, Tabacco G et al (2018) PTH (1\u201334) for surgical hypoparathyroidism: a 2-year prospective, open-label investigation of efficacy and quality of life. J Clin Endocrinol Metab 103:271\u2013280","journal-title":"J Clin Endocrinol Metab"},{"key":"2100_CR9","doi-asserted-by":"publisher","first-page":"2356","DOI":"10.1210\/jc.2013-1239","volume":"98","author":"NE Cusano","year":"2013","unstructured":"Cusano NE, Rubin MR, McMahon DJ et al (2013) The effect of PTH (1\u201384) on quality of life in hypoparathyroidism. J Clin Endocrinol Metab 98:2356\u20132361","journal-title":"J Clin Endocrinol Metab"},{"key":"2100_CR10","doi-asserted-by":"publisher","first-page":"3694","DOI":"10.1210\/jc.2014-2267","volume":"99","author":"NE Cusano","year":"2014","unstructured":"Cusano NE, Rubin MR, McMahon DJ et al (2014) PTH (1\u201384) is associated with improved quality of life in hypoparathyroidism through 5 years of therapy. J Clin Endocrinol Metab 99:3694\u20133699","journal-title":"J Clin Endocrinol Metab"},{"key":"2100_CR11","doi-asserted-by":"publisher","first-page":"3590","DOI":"10.1210\/jc.2015-1855","volume":"100","author":"A Santonati","year":"2015","unstructured":"Santonati A, Palermo A, Maddaloni E et al (2015) PTH (1\u201334) for surgical hypoparathyroidism: a prospective, open-label investigation of efficacy and quality of life. J Clin Endocrinol Metab 100:3590\u20133597","journal-title":"J Clin Endocrinol Metab"},{"key":"2100_CR12","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1210\/jc.2018-02430","volume":"104","author":"G Tabacco","year":"2019","unstructured":"Tabacco G, Tay YD, Cusano NE et al (2019) Quality of Life in hypoparathyroidism improves with rhPTH (1\u201384) throughout 8 Years of therapy. J Clin Endocrinol Metab 104:2748\u20132756","journal-title":"J Clin Endocrinol Metab"},{"key":"2100_CR13","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1007\/s00198-014-2677-6","volume":"25","author":"T Sikjaer","year":"2014","unstructured":"Sikjaer T, Rolighed L, Hess A et al (2014) Effects of PTH(1\u201384) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial. Osteoporos Int 25:1717\u20131726","journal-title":"Osteoporos Int"},{"key":"2100_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/jbmr.4452","volume":"37","author":"KL Roszko","year":"2022","unstructured":"Roszko KL, Hu TY, Guthrie LC et al (2022) PTH 1\u201334 replacement therapy has minimal effect on quality of life in patients with hypoparathyroidism. J Bone Miner Res 37:68\u201377","journal-title":"J Bone Miner Res"},{"key":"2100_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12902-021-00888-2","volume":"21","author":"N Gittoes","year":"2021","unstructured":"Gittoes N, Rejnmark L, Ing SW et al (2021) The PARADIGHM (physicians advancing disease knowledge in hypoparathyroidism) registry for patients with chronic hypoparathyroidism: study protocol and interim baseline patient characteristics. BMC Endocr Disord 21:232","journal-title":"BMC Endocr Disord"},{"key":"2100_CR16","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/BF00688039","volume":"71","author":"T Kumanishi","year":"1986","unstructured":"Kumanishi T, Washiyama K, Saito T et al (1986) Primary malignant lymphoma of the brain: an immunohistochemical study of eight cases using a panel of monoclonal and heterologous antibodies. Acta Neuropathol 71:190\u2013196","journal-title":"Acta Neuropathol"},{"key":"2100_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10479","volume":"5","author":"CU Jorgensen","year":"2021","unstructured":"Jorgensen CU, Homoe P, Dahl M et al (2021) Postoperative chronic hypoparathyroidism and quality of life after total thyroidectomy. JBMR Plus 5:e10479","journal-title":"JBMR Plus"},{"key":"2100_CR18","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1002\/jbmr.2812","volume":"31","author":"T Sikjaer","year":"2016","unstructured":"Sikjaer T, Moser E, Rolighed L et al (2016) Concurrent hypoparathyroidism is associated with impaired physical function and quality of life in hypothyroidism. J Bone Miner Res 31:1440\u20131448","journal-title":"J Bone Miner Res"},{"key":"2100_CR19","doi-asserted-by":"publisher","first-page":"3045","DOI":"10.1210\/jc.2016-1477","volume":"101","author":"MC Astor","year":"2016","unstructured":"Astor MC, Lovas K, Debowska A et al (2016) Epidemiology and health-related quality of life in hypoparathyroidism in norway. J Clin Endocrinol Metab 101:3045\u20133053","journal-title":"J Clin Endocrinol Metab"},{"key":"2100_CR20","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1111\/cen.13593","volume":"88","author":"L Underbjerg","year":"2018","unstructured":"Underbjerg L, Sikjaer T, Rejnmark L (2018) Health-related quality of life in patients with nonsurgical hypoparathyroidism and pseudohypoparathyroidism. Clin Endocrinol (Oxf) 88:838\u2013847","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2100_CR21","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1530\/EJE-12-0946","volume":"168","author":"S Aggarwal","year":"2013","unstructured":"Aggarwal S, Kailash S, Sagar R et al (2013) Neuropsychological dysfunction in idiopathic hypoparathyroidism and its relationship with intracranial calcification and serum total calcium. Eur J Endocrinol 168:895\u2013903","journal-title":"Eur J Endocrinol"},{"key":"2100_CR22","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1007\/s40618-020-01423-1","volume":"44","author":"A Sardella","year":"2021","unstructured":"Sardella A, Bellone F, Morabito N et al (2021) The association between hypoparathyroidism and cognitive impairment: a systematic review. J Endocrinol Invest 44:905\u2013919","journal-title":"J Endocrinol Invest"},{"key":"2100_CR23","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1007\/s40618-022-01822-6","volume":"45","author":"F Saponaro","year":"2022","unstructured":"Saponaro F, Alfi G, Cetani F et al (2022) Serum calcium levels are associated with cognitive function in hypoparathyroidism: a neuropsychological and biochemical study in an Italian cohort of patients with chronic post-surgical hypoparathyroidism. J Endocrinol Invest 45:1909\u20131918","journal-title":"J Endocrinol Invest"},{"key":"2100_CR24","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1007\/s40618-022-01756-z","volume":"45","author":"V Bonavolont\u00e0","year":"2022","unstructured":"Bonavolont\u00e0 V, Cianferotti L, Iolascon G et al (2022) Which physical activity in patients affected by hypoparathyroidism? A review of the literature and practical recommendations. J Endocrinol Invest 45:1289\u20131295","journal-title":"J Endocrinol Invest"},{"key":"2100_CR25","first-page":"227","volume":"106","author":"S Balabanov","year":"1984","unstructured":"Balabanov S, Tollner U, Richter HP et al (1984) Immunoreactive parathyroid hormone, calcium, and magnesium in human cerebrospinal fluid. Acta Endocrinol (Copenh) 106:227\u2013233","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2100_CR26","doi-asserted-by":"publisher","first-page":"15455","DOI":"10.1074\/jbc.270.26.15455","volume":"270","author":"TB Usdin","year":"1995","unstructured":"Usdin TB, Gruber C, Bonner TI (1995) Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor. J Biol Chem 270:15455\u201315458","journal-title":"J Biol Chem"},{"key":"2100_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.neuroscience.2009.04.054","volume":"162","author":"AG Bago","year":"2009","unstructured":"Bago AG, Dimitrov E, Saunders R et al (2009) Parathyroid hormone 2 receptor and its endogenous ligand tuberoinfundibular peptide of 39 residues are concentrated in endocrine, viscerosensory and auditory brain regions in macaque and human. Neuroscience 162:128\u2013147","journal-title":"Neuroscience"},{"key":"2100_CR28","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1210\/jc.2017-01471","volume":"103","author":"TJ Vokes","year":"2018","unstructured":"Vokes TJ, Mannstadt M, Levine MA et al (2018) Recombinant human parathyroid hormone effect on health-related quality of life in adults with chronic hypoparathyroidism. J Clin Endocrinol Metab 103:722\u2013731","journal-title":"J Clin Endocrinol Metab"},{"key":"2100_CR29","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00268-017-4248-4","volume":"42","author":"KH Chomsky-Higgins","year":"2018","unstructured":"Chomsky-Higgins KH, Rochefort HM, Seib CD et al (2018) Recombinant parathyroid hormone versus usual care: do the outcomes justify the cost? World J Surg 42:431\u2013436","journal-title":"World J Surg"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02100-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-023-02100-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-023-02100-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T17:23:17Z","timestamp":1699464197000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-023-02100-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2100"],"URL":"https:\/\/doi.org\/10.1007\/s40618-023-02100-9","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,2]]},"assertion":[{"value":"30 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no confict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the principles of the Declaration of Helsinki and approved by the Ethics Committee of PUMCH (ZS-1689).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Each patient signed the informed consent document before the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}